MARIO
FERNÁNDEZ RUIZ
Profesor asociado de Ciencias de la Salud
![Foto de MARIO](/img/nophoto.png)
![Foto de Hospital Clinic Barcelona](/img/noimage_org.png)
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (24)
2023
-
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients
Transplantation Reviews
-
Transplantation of organs from SARS-CoV-2-positive donors: Preliminary experience from Spain
Transplant Infectious Disease, Vol. 25, Núm. 1
2022
2021
-
COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?
Transplantation, Vol. 105, Núm. 10, pp. 2146-2155
-
COVID-19 in transplant recipients: The Spanish experience
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, Vol. 21, Núm. 5, pp. 1825-1837
-
Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience
Transplantation, Vol. 105, Núm. 1, pp. 29-36
2020
-
Derivation and external validation of the SIMPLICITY score as a simple immune-based risk score to predict infection in kidney transplant recipients
Kidney International, Vol. 98, Núm. 4, pp. 1031-1043
-
Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus
Transplantation Reviews, Vol. 34, Núm. 2
2018
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)
Clinical Microbiology and Infection, Vol. 24, pp. S2-S9
-
Vitamin D deficiency and infection risk in kidney transplant recipients: A single-center cohort study
Transplant Infectious Disease, Vol. 20, Núm. 6
2017
-
Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis
Clinical Infectious Diseases, Vol. 64, Núm. 10, pp. 1374-1379
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
The Lancet Infectious Diseases, Vol. 17, Núm. 7, pp. 726-734
-
Empiric Therapy with Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results from the INCREMENT Cohort
Clinical Infectious Diseases, Vol. 65, Núm. 10, pp. 1615-1623
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
-
High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2102-2109
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
2016
-
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Mayo Clinic Proceedings, Vol. 91, Núm. 10, pp. 1362-1371
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9